Vericel

Vericel EBIT per Employee

EBIT per Employee of Vericel (VCEL) as of Oct 26, 2026.

EBIT per Employee

-USD

Last updated:

EBIT per Employee of Vericel is 2026 - USD. EBIT per Employee of Vericel was 2025 - USD. It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Vericel Stock analysis

What does Vericel do? Vericel Corp is a US biotechnology company specializing in the development and commercialization of innovative cell therapies for patients with serious diseases. The company is headquartered in Cambridge, Massachusetts and was founded in 1997. Vericel is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Vericel stock

On Eulerpool you can find the complete historical development of EBIT per Employee Vericel since 2006 – with annual values, charts, and detailed analysis.

EBIT per employee measures operating profit per employee, showing how efficiently the workforce generates operating earnings.

EBIT per Employee's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT per Employee's Vericel historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — Vericel

All Key Metrics — Vericel